معرفی
Dr. Flaminia Talos is an Assistant Professor in the Departments of Pathology and Urology at Stony Brook University's Renaissance School of Medicine. She maintains her laboratory at the BST Level 8 facility of Stony Brook Medicine in New York.
Her educational background includes a PhD in Molecular and Cellular Biology from Stony Brook University (2006) and an MD from the University of Medicine and Pharmacy 'Iuliu Hatieganu' in Cluj-Napoca, Romania (2000). Her professional journey began with surgical training in France and clinical practice in Romania before transitioning to research.
Dr. Talos's research program focuses on the molecular mechanisms underlying prostate development, homeostasis, and carcinogenesis. Her work integrates stem cell biology, genomics, and computational approaches to understand epithelial cell dynamics in prostate tissue. She has made significant contributions to understanding the roles of p53 family proteins in genome stability and cancer development, as well as the cellular mechanisms driving prostate cancer progression.
Her publication record demonstrates a strong focus on prostate cancer biology, with particular expertise in stem cell dynamics, clonal evolution, and computational systems approaches to understanding disease mechanisms. Recent work has explored immune interactions in prostate cancer microenvironments and DNA replication mechanisms in oncogenesis.
- Erasmus European Exchange Program Scholarship (2000)
- Urology Care Foundation Research Scholars Award (2012-2014)
- National Cancer Institute (NCI) Career Transition Award (K22, NCI #1K22CA188169-01) for 'Clonal analysis of epithelial stem cells in prostate regeneration and cancer' (2014)
Dr. Talos has built a robust research program supported by competitive federal funding, particularly through her NCI K22 award. Her work bridges basic science and clinical applications in urological pathology, with a focus on translating molecular discoveries into potential therapeutic approaches for prostate cancer. She is an active member of the International Society for Stem Cell Research (ISSCR) and the American Association for Cancer Research (AACR), contributing to the broader scientific community through these professional organizations.
